4-(Morpholinomethyl)aniline

Catalog No.: 
ACPQOI367
CAS No.: 
51013-67-3
Molecular Formula: 
C11H16N2O
Molecular Weight: 
192.26
4-(Morpholinomethyl)aniline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g97%$66.00In stockIn stock
25g97%$80.00In stockIn stock
100g97%$298.00In stockIn stock
500g97%$1132.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Morpholinomethyl)aniline
IUPAC Name4-(morpholinomethyl)aniline
MDL No.MFCD03659020
Molecular FormulaC11H16N2O
Molecular Weight192.26
SMILESNC1=CC=C(CN2CCOCC2)C=C1
InChI KeyWNYFVEFUHMDIRQ-UHFFFAOYSA-N
Synonym4-(morpholinomethyl)aniline | 51013-67-3 | 4-(morpholin-4-ylmethyl)aniline | 4-Morpholin-4-ylmethyl-phenylamine | 4-morpholin-4-ylmethylphenylamine | 4-morpholin-4-ylmethyl-aniline | 4-[(morpholin-4-yl)methyl]aniline | MFCD03659020 | benzenamine, 4-(4-morpholinylmethyl)-
CAS No.51013-67-3
PubChem CID776851

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACPQOI367 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPQOI367 route product structure diagram
    ACPQOI36751013-67-3In Stock
Inquiry

2. ACPQOI367 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPQOI367 route product structure diagram
    ACPQOI36751013-67-3In Stock
Inquiry

3. ACPQOI367 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPQOI367 route product structure diagram
    ACPQOI36751013-67-3In Stock
Inquiry

Comments (0)